COVID-19, Influenza A/B, Seasonal Influenza A subtyping, Influenza A/H5 and Influenza A/H7 Extraction Reagents
SAM.GOV Due: April 29, 2025 at 09:00 PM UTC
In-Active Special Notice Source Url

Summary

The United States Department of the Naval Medical Research Command (NMRC) is seeking to award a sole source contract to Roche Diagnostics Corporation for the provision of extraction reagents necessary for COVID-19 and various influenza assays. This contract involves the drop shipment of specific Roche supplies, which are critical for conducting 1,000 extraction reactions every two months over a period of six shipments, totaling 6,000 reactions. The reagents are essential for the Naval Infectious Diseases Diagnostic Laboratory's operations, and the requirement emphasizes the need for brand name equipment due to the unique qualifications of Roche products. Contractors with capabilities in providing these specific reagents and who are registered with the Systems for Award Management (SAM) are encouraged to submit capability statements for consideration, although this is not a competitive proposal request.
Description

The United States Department of the Naval Medical Research Command (NMRC) intends to award a sole source contract to, Roche Diagnostics Corporation, Indianapolis, Indiana. This requirement is for brand name equipment. This notice is not a request for competitive proposa

Entities
DOD
Department of Defense
DOTN
Department of the Navy
NAICS
325413
Set Aside
None
Place of Performance
Maryland 20910
Point of Contact
Full Name Email Phone Type
SHAMAI CARTER [email protected] primary
DEBORAH SHARPE [email protected] secondary
Attachments
  • ERP+1301243163+JA_Redacted.pdf